Skip to main content

Table 1 Age and hormone status as determined by OHSU pathology

From: Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations

Tumor samples

Age

ER status by IHC

PR status by IHC

21 T

40

Positive

Positive

23 T

67

Positive

Positive 60%

30 T

45

Positive

Positive

46 T

64

90%

Positive 35%

50 T

79

Positive

Positive

51 T

60

Positive

Positive 3%

52 T

58

Positive

Positive

53 T

60

Positive

Positive 80%

54 T

51

Positive

Positive

13 T

52

Positive

Positive 95%

19 T

72

Positive

Positive 95%

20 T

60

Positive

Positive 95%

78 T

79

Positive

Positive 30%

79 T

59

Positive

Positive 75%

82 T

90

Positive

Positive

85 T

61

Positive

Positive 60%

88 T

59

Positive

Negative

103 T

78

93%

Positive 26%

113 T

54

Positive

Positive 80%

115 T

67

Positive

Positive 100%

16 T

59

Negative

Negative

22 T

73

Negative

Negative

28 T

59

Negative

Negative

39 T

52

Negative

5%

55 T

54

Negative

Negative

69 T

46

Negative

Negative

102 T

69

Negative

Negative

112 T

35

Negative

Negative

122 T

54

Negative

Negative

  1. Positive denotes samples that are greater than 95% positive unless otherwise indicated. Median age of patients with ER positive tumors is 60 ± 12.7 yr. (range 40–90 yr., mode = 60 yr.). Median age of patients with ER negative tumors is 54 ± 12.1 yr. (range 35–73 yr., mode = 59 yr.).